作者
Emanuel L Peter, Andrew G Mtewa, Prakash B Nagendrappa, Anita Kaligirwa, Crispin Duncan Sesaazi
发表日期
2020/12
来源
Systematic Reviews
卷号
9
页码范围
1-9
出版商
BioMed Central
简介
Background
Studies on several preclinical models of type 2 diabetes mellitus have been conducted to establish the hypoglycemic activity of Momordica charantia L. Concerned with appropriateness of these models, we designed a systematic review to establish the efficacy and safety of M. charantia L. in preclinical models of type 2 diabetes mellitus.
Methods
Review authors will search without language restriction in MEDLINE/PubMed, Web of Science, Embase, Scopus, and CINAHL databases through April 2019. Search filters will be applied to enhance search efficiency. The authors will search for gray literature in Google and Google Scholar, OpenGrey, and ProQuest Dissertations & Theses. Two authors will evaluate full texts, extract data, and asses risk of bias independently. The review will include randomized or non-randomized studies that …
引用总数
201920202021202220232024125152